Your browser doesn't support javascript.
loading
FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer.
Zaghdoudi, Sonia; Decaup, Emilie; Belhabib, Ismahane; Samain, Rémi; Cassant-Sourdy, Stéphanie; Rochotte, Julia; Brunel, Alexia; Schlaepfer, David; Cros, Jérome; Neuzillet, Cindy; Strehaiano, Manon; Alard, Amandine; Tomasini, Richard; Rajeeve, Vinothini; Perraud, Aurélie; Mathonnet, Muriel; Pearce, Oliver Mt; Martineau, Yvan; Pyronnet, Stéphane; Bousquet, Corinne; Jean, Christine.
Afiliación
  • Zaghdoudi S; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Decaup E; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Belhabib I; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Samain R; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Cassant-Sourdy S; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Rochotte J; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Brunel A; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Schlaepfer D; Department of Reproductive Medicine Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
  • Cros J; Department of Pathology, Beaujon Hospital, INSERM U1149, Clichy, France.
  • Neuzillet C; Medical Oncology Department, Curie Institute, Versailles Saint-Quentin University, Saint-Cloud, France.
  • Strehaiano M; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Alard A; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Tomasini R; Cancer Research Center of Marseille, INSERM U1068, Marseille, France.
  • Rajeeve V; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Perraud A; EA 3842 Laboratory, Medicine and Pharmacy Faculties, Limoges University, Limoges, France.
  • Mathonnet M; EA 3842 Laboratory, Medicine and Pharmacy Faculties, Limoges University, Limoges, France.
  • Pearce OM; Centre for Tumour Microenvironment, Barts Cancer Institute, London, UK.
  • Martineau Y; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Pyronnet S; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Bousquet C; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
  • Jean C; Cancer Research Center of Toulouse (CRCT), team 6 "Protein synthesis & secretion in carcinogenesis", Equipe labellisée Ligue Contre Le Cancer, Labex TOUCAN, INSERM UMR 1037- University Toulouse III Paul Sabatier, Toulouse, France.
EMBO Mol Med ; 12(11): e12010, 2020 11 06.
Article en En | MEDLINE | ID: mdl-33025708
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Fibroblastos Asociados al Cáncer Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Fibroblastos Asociados al Cáncer Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EMBO Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2020 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido